. MALDI-TOF MS of 4 (top) and 5 (bottom). Intensity Intensity S10 Figure S9 . CD spectra of 6 (left) and 7 (right) at 20°C.
Figure S10. CD spectra of 1 at r.t. 6, 153, 150.2, 149.4, 148.9, 112.3, 86.1, 79.6, 71.4, 70.7, 62.8, 56.5, 34.9, and 19; IR 3403, 3129, 1727 IR 3403, 3129, , 1359 , and 1337 cm 
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6-N-(Dimethyl formamidine)-5'-(4,4'-Dimethoxytrityl)-8-oxoadenosine (S2)
. Derivative S1 (5.5 g, 16.3 mmol) was azeotropically dried over pyridine (15 mL). The solid was re-dissolved in pyridine (30 mL) and cooled to 0℃ followed by addition of 4,4'-Dimethoxytriphenylmethyl chloride (6 g, 17.7 mmol). The mixture was stirred overnight upon warming to rt, followed by addition of aq NaHCO 3 (15 mL, 10 %). The organic residues were extracted with DCM (3 × 20 mL), dried over brine (25 mL) and sodium sulfate, and concentrated under reduced pressure to dryness. Flash chromatography (DCM:MeOH, gradient from 0 to 10 % MeOH) yielded S2as a white foam (6.5 g, 10.1 mmol, 62 % 1, 149, 148.5, 145, 130.2, 128.3, 127.7, 126.6, 113, 111.7, 86.1, 83.2, 71.5, 70.3, 64, 55.2, 50.4, 45.9, 41.3, and 35 . HRMS m/z calculated for C 34 H 37 N 6 O 7 (M + + H), 641.2724, observed m/z = 641.2722.
6-N-(Dimethyl formamidine)-5'-(4,4'-Dimethoxytrityl)-C2'O-(t-butyldimethylsilyl)-8-oxoadenosine
(S4). A mixture of derivative S2 (0.57 g, 0.9 mmol), THF (12 mL), pyridine (0.43 mL, 5.34 mmol), and AgNO 3 (0.30 g, 1.77 mmol) were stirred at room temperature for 30 min. Addition of a t-butyldimethylsilyl chloride solution in toluene (0.22 mL, 1.26 mmol) was followed with stirring for 12 h. The white suspension was added to a NaHCO 3 solution (sat. 15 mL) and extracted with ethyl acetate (3 × 15 mL).
The organics were dried over brine (15 mL) and sodium sulfate followed by concentration under reduced pressure. Flash chromatography (EtOAc:Hexanes gradient from 80 % to 100% EtOAc) yielded nucleoside S4 in the form of a white foam (first fraction, 0.3 g, 0.51 mmol, 58 % 
6-N-(Dimethyl formamidine)-5'-(4,4'-Dimethoxytrityl)-C3'O-(t-butyldimethylsilyl)-8-oxoadenosine (S3
6-N-(Dimethyl formamidine)-5'-(4,4'-Dimethoxytrityl)-C2'O-(t-butyldimethylsilyl)-C3'O-(ethylcyano-
N
6-N-(Dimethyl formamidine)-5',3'-O-bis-(-t-butylsilyl)-2'-O-( t-butyldimethylsilyl)-8-oxoadenosine
(S5). A flask containing a solution of nucleoside S1 (0.4g, 1.18 mmol) and silver nitrate (0.5 g, 2.9 mmol) dissolved in DMF (6 mL) was cooled down to 0 ° C followed by addition of di-t-butyldichlorosilane (0.3g, 1.4 mmol). The gray suspension was stirred for 15 min and triethylamine (2 mL) was added at once. The
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solution was filtered into a flask containing aq. NaHCO 3 (15 mL, 10%) and extracted with ethyl acetate (12 mL× 3). The organics were dried over brine and Na 2 SO 4 and concentrated under reduced pressure to obtain a white foam which was transferred into a round bottom flask containing silver nitrate (0.17g, 1 mmol) and imidazole (0.08g, 1.16 mmol). THF (10 mL) was added and the resulting white suspension was stirred for 10 min. TBDMSCl (0.15g, 1 mmol) was added at once with stirring for 18 h. The suspension was filtered into a flask containing aq. NaHCO 3 (15 mL, 10%) and extracted with ethyl acetate (12 mL× 4, 152.3, 151, 149, 148 112, 89.4 75.4, 74.3, 73.9, 67.7, 41.4, 35.2, 27.6, 27.1, 25.9, 22.7, 20.3, 18.4, -4 
6-N-(Dimethyl formamidine)-2'-O-( t-butyldimethylsilyl)-8-oxoadenosine (S6). A solution of
nucleoside S5 (0.04 g, 0.067 mmol) dissolved in DCM (2 mL) was cooled to -20° C followed by addition of a solution of triethylamine trihydrofluoride (0.05 g, 0.3 mmol) in pyridine (0.1 mL). The solution was stirred and warmed to 0° C over 2.5 h. NaHCO 3 (0.02 g, 0.24 mmol) and wet MeOH (1 mL 15-5.13 (m, 1H), 4.29-4.27 (m, 1H), 4.16-4.14 (m, 1H), 3.88-3.84 (m, 1H), 3.74-3.71 (m, 1H), 3.23 (s, 3H), 3.20 (s, 3H) , 0.83 (s, 9H), -0.03 (s, 3H), and -0.11 (s, 3H); 13 C NMR 153, 150, 149.8, 148.2, 112.2, 86.6, 86.3, 72.7, 72, 65.5, 62.8, 40, 33.9, 24.8, 17.6, 14.1, ): 3,233, 2,929, 2,857, 1,716, 2,661, and 2,333 
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